Press Release: PNP Therapeutics : PNP Therapeutics Inc. Receives Orphan Drug Status for Gedeptin

BIRMINGHAM, Ala., June 16, 2015 /PRNewswire-USNewswire/ -- PNP Therapeutics Inc. announced today the Food and Drug Administration has granted orphan drug status to Gedeptin , the Company's lead product candidate (adenoviral vector expressing E. coli purine nucleoside phosphorylase...